Get the Stockscreener App
4.59
0.00%
0.00
After Hours:
4.59
Oncology Institute Inc stock is traded at $4.59, with a volume of 1.67M.
It is up +0.00% in the last 24 hours and up +41.23% over the past month.
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
See More
Previous Close:
$4.59
Open:
$4.61
24h Volume:
1.67M
Relative Volume:
0.91
Market Cap:
$458.92M
Revenue:
$545.76M
Net Income/Loss:
$-36.28M
P/E Ratio:
-12.23
EPS:
-0.3754
Net Cash Flow:
$-25.73M
1W Performance:
+11.95%
1M Performance:
+41.23%
6M Performance:
+47.12%
1Y Performance:
+51.99%
1-Day Range:
$4.34
$4.785
1-Week Range:
$4.02
$4.785
52-Week Range:
$2.015
$4.88
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
4.59 | 458.92M | 545.76M | -36.28M | -25.73M | -0.3754 |
HCA
Hca Healthcare Inc
|
392.42 | 87.42B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
176.38 | 14.97B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
195.57 | 12.74B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.58 | 11.62B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
104.91 | 10.41B | 6.07B | 793.80M | 464.40M | 5.9914 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-25-25 | Initiated | Needham | Buy |
| Jul-23-25 | Initiated | Noble Capital Markets | Outperform |
| Jul-16-25 | Initiated | B. Riley Securities | Buy |
| May-15-25 | Initiated | BTIG Research | Buy |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
View All
Oncology Institute Inc Stock (TOI) Latest News
The Oncology Institute CMO to speak at healthcare conference By Investing.com - Investing.com Canada
Cancer group CMO to discuss value-based care and costs at APG forum - Stock Titan
Oncology Institute Data Breach 2026: Third-Party Vendor Compromise Exposes Patient Data in Kroll-Administered Systems - Rescana
Third-Party Cyberattack Impacts Patient Information at The Oncology Institute - Security Affairs
Number of shareholders of The Oncology Institute, Inc. – NASDAQ:TOI - TradingView
The Oncology Institute Reports Cybersecurity Incident Affecting Software Vendor – Form 8-K Filing May 2026 - Minichart
Oncology Institute (TOI) CEO logs tax-related restructuring of 23,058 shares - Stock Titan
Oncology Institute (NASDAQ: TOI) CMO logs 1,805-share RSU tax-cover trade - Stock Titan
Oncology Institute (TOI) CFO shares sold to cover RSU tax liabilities - Stock Titan
Oncology Institute's Patient Data Exposed in Cybersecurity Incident - Moomoo
Cyber incident at vendor impacts The Oncology Institute (NASDAQ: TOI) patient data systems - Stock Titan
TOI SEC FilingsThe Oncology Institute Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Jorey Chernett buys $156,595 of Oncology Institute stock - Investing.com
Insider boosts Oncology Institute (TOI) stake with 38,500-share open-market buys - Stock Titan
Oncology Institute chiefs to host B. Riley investor fireside chat - Stock Titan
Ten percent owner Jorey Chernett buys $122,700 of Oncology Institute stock - Investing.com India
Ten percent owner Jorey Chernett buys $122,700 of Oncology Institute stock By Investing.com - Investing.com South Africa
Ten percent owner of Oncology Institute (NASDAQ: TOI) adds 30,000 shares in open-market buy - Stock Titan
Oncology Institute Q1 earnings call highlights - MSN
M33 Growth I LP trims Oncology Institute (NASDAQ: TOI) stake with 1.8M-share sale - Stock Titan
The Oncology Institute, Inc.Common Stock (NQ: TOI - FinancialContent
The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference - The Manila Times
Oncology Institute (TOI) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
The Oncology Institute, Inc. (NASDAQ:TOI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00 - Yahoo Finance
The Oncology Institute, Inc. (NASDAQ:TOI) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
Number of shareholders of The Oncology Institute, Inc. – NASDAQ:TOIIW - TradingView
BTIG Remains a Buy on Oncology Institute (TOI) - The Globe and Mail
Oncology Institute Q1 Earnings Call Highlights - MarketBeat
Oncology Institute Earnings Call Highlights Growth Pivot - TipRanks
Needham Initiates Coverage of Oncology Institute (TOI) with Buy Recommendation - MSN
Noble Financial Maintains The Oncology Institute(TOI.US) With Buy Rating, Maintains Target Price $8 - Moomoo
BTIG Maintains The Oncology Institute(TOI.US) With Buy Rating, Maintains Target Price $7 - Moomoo
The Oncology Institute, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Oncology Institute beats Q1 2026 forecasts By Investing.com - Investing.com South Africa
MSN Money - MSN
The Oncology Institute Reports First Quarter 2026 Financial Results - The Manila Times
ONCOLOGY INSTITUTE INC/THE (NASDAQ:TOI) Beats Q1 Estimates, Raises Free Cash Flow Outlook - ChartMill
Earnings call transcript: Oncology Institute beats Q1 2026 forecasts - Investing.com
Oncology Institute Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Oncology Institute : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
The Oncology Institute Inc. (TOI) stock rises on Q1 2026 Earnings - Quiver Quantitative
Cancer care group says Medicare savings neared $2M as revenue rose 41% - Stock Titan
Oncology Institute (NASDAQ: TOI) grows Q1 revenue 41% and boosts 2026 cash outlook - Stock Titan
[10-Q] Oncology Institute, Inc. Quarterly Earnings Report - Stock Titan
The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.01%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):